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Abstract
Background: Despite growing HIV and cancer prevalence in Sub-Saharan Africa, and WHO
advocacy for a public health approach to palliative care provision, opioid availability is severely
limited. Uganda has achieved a morphine roll-out programme in partnership with the Ministry of
Health. This study aimed to evaluate that programme by identifying challenges to implementation
that may inform replication.
Methods: A multi-methods protocol appraised morphine regulation, storage, prescribing, and
consumption in three phases: key informant interviews throughout the opioid supply chain, and
direct observation and audit of clinical practice.
Results: Regulation had achieved its goal of preventing misuse and leakage from the supply chain.
However, the Government felt that relaxation of regulation was now appropriate. Confusion and
complexity in storage and authorisation rules led to discontinuation of opioid pain management at
the patient level and also wasted service time in trying to obtain supplies to which they were
entitled. Continued neglect to prescribe among clinicians and public fear of opioids led to under
prescribing, and clinical skills showed some evidence of need for improvement with respect to
physical assessment and follow-up.
Conclusion:  The Ugandan programme offers a successful model for both advocacy and
Governmental support in achieving opioid roll-out across health districts. Despite initial concerns,
abuse of opioids has not been evident. Further work is required to ensure that available supplies
of opioids are prescribed to those in need, and that clinical standards are met. However, the
programme for roll-out has proved a useful model to expand opioid availability as the first step in
improving patient care, and may prove a useful template for other Sub-Saharan African countries.
Background
Most, if not all, pain due to cancer and AIDS could be
relieved if we implemented existing medical knowledge
[1]. This does not happen for two thirds of the world's
population for several reasons. Most live in countries with
weak public health infrastructure and, despite WHO
encouragement for a public health approach to pain man-
agement and palliative care [2], a lack of legislative and
policy support exists. Despite an HIV/AIDS epidemic
which kills 3 million each year, inadequate availability of
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pain medication, especially of opioids, is evident in that
only eleven out of forty seven African countries use mor-
phine for chronic pain and, of these eleven, the amount
consumed is tiny [3]. South Africa is highest user on the
continent consuming 265 daily defined doses (DDD)
while Namibia uses 97 and Uganda 9 DDDs, and eighty-
six percent of the world's morphine is still used by the 20
richest countries [4]. Sadly, although morphine is a safe
drug which can be used with anti-retroviral therapy,
chemotherapy and traditional medicines, it is under-used
largely due to professional fears.
Uganda is the first African country to follow the WHO
guidelines, and, despite limited resources and a popula-
tion which is 90% rural, has prioritised palliative care
under Essential Clinical Services in the National Health
Plan (2001–2005). It has made oral morphine freely
available to those districts that have specialist palliative
care nurses or clinical officers and has promoted mor-
phine use down to village level. It has passed laws to allow
nurse prescribing of morphine [5], an essential step as
doctors are scarce in rural areas. There are no limits to the
number of days, nor dose, which doctors or trained nurses
and clinical officers can prescribe within the hospice set-
ting, though only the weaker strength (5 mgs per 5 mls)
was available to community nurses outside the Hospice
setting.
Since 1993, Hospice Africa Uganda (HAU), a non-govern-
mental organisation, has pioneered three community-
based palliative care programmes in rural and urban local-
ities. However, coverage has been comparatively low. In
1998, following several years of lobbying, the Ministry of
Health invited hospice staff to be technical experts in a
pilot study in 15 (out of 56) rural and urban districts to
assess the feasibility and safety of using morphine for
chronic pain in the community. This included cancer
pain, pain from HIV/AIDS disease, and pain from sickle
cell crisis. In 2002–03, the 15 districts, including mission
hospitals, underwent extensive initial training involving
local dignitaries, police, and senior health officials. The
programme is still in the early stages and has faced chal-
lenges in funding, staffing and supervision. This paper
reports an evaluation of the Ugandan morphine access
programme, which aimed to appraise the processes of
morphine supply, to assess clinical practice on prescribing
and pain control, and investigate patient satisfaction with
symptom control and costs. This initial outline of a work-
ing model of morphine access, achieved through policy,
legislative and clinical efforts, was developed as an exam-
ple for the continent. The strengths and blockages in the
system of morphine delivery are described.
Methods
Setting
The study was undertaken in 2003 across rural and urban
Ugandan hospice sites, two of the pilot districts Govern-
ment District Hospitals, the Ministry of Health, and 2
home-based care NGO programmes. Ethics permission
was obtained from the Ethics Committee of Liverpool
School of Tropical Medicine and from Hospice Africa
Uganda. Permission from participants was obtained by
reading a standard permission sheet which explained
about the survey, that it was confidential, voluntary, and
would report anonymously. This was translated into local
languages
Procedure
The evaluation protocol employed mixed data collection
methods from stakeholders throughout the supply chain.
Phase 1: semi-structured interviews among three popula-
tions. Firstly, clinicians prescribing morphine (n = 16);
secondly, patients accessing morphine (n = 10); thirdly,
key informants (n = 16) including senior clinical and Gov-
ernmental staff. Interviews were voluntary and confiden-
tiality was assured. Translation for patients was provided.
Interviews were tape recorded, transcribed verbatim and
thematically coded, and themes developed adopting
framework analysis [6] using Winmax software.
Phase 2: direct observation of morphine from entry to the
country to a pharmaceutical NGO and on to distribution
through hospital wards and patients' homes. Pharmacy,
ward and nursing records were checked against legal
requirements [7].
Phase 3: two quality of clinical care audits across two hos-
pice sites, urban and rural. The first audit observed domi-
ciliary nurse visits prescribing oral morphine (n = 21), the
second retrospectively examined prescribing standards in
randomly-sampled clinical notes (n = 50). Criteria were
established using local prescribing guidelines and clinical
best-practice literature [8-10]. The random files sample
was generated by selecting every 5th deceased patient file
for deaths recorded during a 12-month period 2002–
2003.
Results
The data on barriers and blockages in morphine supply
are represented in the model in Figure 1.
Morphine regulations
Opioids are monitored by the International Narcotics
Control Board which aims to promote Government com-
pliance with international drug treaties and assist them in
this effort. The National Drug Regulatory Authority oper-
ates through the Ugandan Ministry of Health, whichBMC Public Health 2005, 5:82 http://www.biomedcentral.com/1471-2458/5/82
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estimates Uganda's needs each year and writes laws which
cover the production of Class A drugs (WHO schedule 2)
manufacture, distribution, use, and registration of all han-
dlers. Uganda has produced model regulation guidelines
[11] which are available as a model for other countries.
Uganda uses morphine sulphate made up generically in-
country from powder to liquid and costing between 1.8–
5.6 US$ per patient per month [12]. It is stable in liquid
form without refrigeration for up to three months making
it especially suitable for community use.
When the scaling up of morphine use to the community
was first discussed, there was suspicion from politicians,
police and senior doctors who feared Uganda would
become "a smugglers paradise". Therefore, the balance
between encouraging use and preventing misuse was
weighted towards safety. As there has not been a single
case of narcotic abuse over the twelve years of hospice and
three years of government use, there was a reported con-
sensus view among Governmental and regulatory bodies
that initial caution could be relaxed. This may have a sig-
nificant patient impact.
"Nurses fear blame if they cannot account for all their supplies
of morphine. A 24-year old man with Kaposi's sarcoma was
found at home in a remote area, in great pain, with gross liver
distension and dehydration. Worried about the inadequacy of
pain relief it was suggested that an extra bottle (250 mls) might
be left in case of breakthrough pain. The nurse prescriber was
reluctant. She agreed he might soon die but argued that she
might not then be able to retrieve the unused supply. The man
was not seen again and was reported dead a few days later he
died with prolonged convulsions. The nurse said: "Some of our
clients have passed away and we can't find out where the mor-
phine is. The previous doctor was very strict and he would check
our books".
Regulation involves checking authorisation, complex
book-keeping, drug storage, and occasionally caused
blockages in the morphine flow (see Figure 1). Confusion
arose over accreditation of NGO health professionals who
had to obtain supplies through the district hospitals, as
opposed to through national medical stores. One pallia-
tive care trained doctor from an NGO was refused mor-
phine as the district hospital wanted written evidence of
authority, without providing the necessary clarity about
how this could be obtained. As a result a major NGO
treating HIV/AIDS was without morphine. Double
authorisation meant that district hospital teams had to
visit two locations (MOH and medical stores) in Kampala
for renewed supplies. Staff experienced difficulty in find-
ing the appropriate person to authorise the prescription
and one nurse waited 6 hours for a signature. Another had
to make two journeys from up-country occupying a scarce
hospital vehicle.
The regulations dictate that morphine must be double
locked in a secure cupboard attached to the wall. Often
pharmacy rooms were inadequate or cupboards too small
to hold 500 mls bottles. Obtaining bigger cupboards was
a major challenge because of different funding pathways.
Drug record books could be difficult to obtain and some
clinical staff found them complex to complete.
"We started to introduce morphine. They (our patients) need
it. The problem is we don't have a locked cupboard......and the
Morphine supply and blockages within the Ugandan regula- tory framework Figure 1
Morphine supply and blockages within the Ugandan regula-
tory framework. Blockages in morphine flow: key.  District 
Hospital has to obtain permission from MOH for every order 
and take this to JMS.  National Medical Stores currently re-
structuring and lacks capacity and drug inspectors.  Mission 
hospitals and NGOs have to obtain morphine via District Hos-
pital pharmacy and depend on the co-operation of the phar-
macist/dispenser.  Pharmacy may be slow in re-ordering. 
Local health centre/hospice level, drug cupboard may not be 
adequate, record books may be missing, there may be staff 
turn over resulting in loss of know-how.
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pharmacy is so small. It sounds easy (to put right) but they have
a different administration (from the health authorities)".
NGO Prescriber
"Often the pharmacist/dispenser in the hospital knew how to
fill out the books however there was lack of consistency in how
it was undertaken between different hospitals". Hospice Staff
New laws have been introduced allowing nurse prescrib-
ing but, until recently, doctors had to counter-sign pre-
scriptions. The ease of achieving this depended on the
doctors' attitude and much nursing time was spent chas-
ing signatures. One nurse said that some health profes-
sionals do not see the terminally ill as a priority.
Under-use of morphine
The patients were grateful to have been prescribed mor-
phine which reportedly improved their quality of life, felt
that it prolonged life, and had few side effects (at 5 mgs
per 5 mls, the only strength available at District level).
One patient said "I cannot imagine being in that state (of
pain) again". However professional fears about morphine
proved difficult to shift and, despite undergoing a 5-day
training programme, one district hospital returned the
first supplies unused.
"There are 10 doctors in the hospital and only 3 are willing (to
sign prescriptions). The others you have to keep begging. I visit
one ward with cancer and HIV patients and there I have to keep
asking him to write but he doesn't write. He doesn't take it seri-
ously or he doesn't think he should take it from a nurse who is
lower (than he is)". Nurse Prescriber
Some nurses blamed doctors for perpetuating fears that
morphine hastened death while others thought public
opinion responsible. In one rural area local radio was
used to re-assure people that the palliative care team "do
not kill".
"In Hoima they say "when you go to that doctor you are going
to die(because they give strong medicine) so we are starting to
plan a radio programme maybe quarterly or monthly to talk
about palliative care and try to wipe away that image that we
kill". Nurse Prescriber
Lack of essential drug and human resource shortages
Morphine should be used with other analgesics according
to the WHO analgesic ladder. Use was curtailed if the dis-
trict hospital ran out of simple analgesics or laxatives.
Patients were asked to buy such supplies and many could
not afford to do so.
Staff shortages also hindered availability. Although the
HAU is well-staffed, government hospitals had severe
nurse shortages. The tertiary referral hospital in Kampala
with 33 wards had only one palliative care nurse to pre-
scribe and monitor morphine (a second was in training).
She covered only two wards, cancer and gynaecology, and
palliative care was unavailable to many HIV/AIDS
patients.
With only 200 pharmacists in the country, and 300 phar-
maceutical assistants, fewer than 10 Districts in Uganda
have a trained pharmacist. Nurses felt that having a phar-
macist with a positive attitude to morphine use was key to
obtaining uninterrupted supplies. The serious shortage of
drug inspectors also weakened the functioning of the
system.
Quality of care
Quality was measured in two audits (phase 2) from rural
and urban hospice sites (see Table 1). Clinical care stand-
ards in trained nurses were high although, in 7 cases, the
clinical examination was considered by the observer to be
incomplete (no torch examination of the mouth, no
abdominal or rectal examination in the presence of con-
stipation, no examination of the spine in suspected verte-
bral collapse). Validated pain measurement to titrate
morphine was under-used in both audits with a reduction
in completion of pain scores across successive visits. Fol-
low up after starting morphine is important to assess ade-
quacy of pain relief and potential side effects. Thirty-eight
patients (76%) were not re-visited within the recom-
mended 3 days, and in 25 cases (50%) the follow-up was
5 days or longer. The method of procuring further mor-
phine was not clear in 74% of notes (n = 37) although the
information may have been verbally delivered. However,
prescription details were clearly written in 84% files (n =
42).
Identifying patients and following them up
The logistics of identifying and following-up patients in
rural areas are complex. With only one dedicated vehicle
or a communal hospital vehicle, co-operation with com-
munity volunteers was invaluable. One rural hospice
team said they could not function without them. Such
liaisons ran into trouble for lack of funds to pay even
expenses, let alone "incentives". If a patient lived far away,
the volunteer or relative were asked to return for repeat
drugs and report progress, but this incurred expense and
time. Frequently, patients presented late and were not
reviewed after the first morphine prescription.
Costs to patient
Although user fees were officially banned in Uganda in
2002, charges for treatment are still in place as financial
pressures are passed on. The Hospice charged patients
5,000 shillings (£2.70) per week for all care including
drugs, which only one third could afford. Even when mor-
phine is free, patients expressed distress at the costs ofBMC Public Health 2005, 5:82 http://www.biomedcentral.com/1471-2458/5/82
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transport to collect it. Some patients move nearer to clin-
ics in order to access a continuous supply of pain relieving
drugs, subsequently ending their lives far from their chil-
dren and families.
"If I am in Congo there is nothing there (no drugs). For 2
months in Congo I was without drugs. I spread the dose (2
week's worth) out for 2 months. I'd like to go home but can't
because of the tablets. That is why I am here". Patient
"I stay about 30 miles away but I come to stay in my son's place
in Kampala. The Hospice picks me up with their transport
(weekly). It costs 5,000 shillings (£2.75) every week for the
hospice. But the journey home costs 6,000 shillings (£3) to my
village. If I can find transport money I go home. Usually once
a month to look after my garden". Patient
Discussion
From this initial evaluation of this innovative multi-
agency morphine roll-out programme, we wish to dissem-
inate 5 key lessons learned from the Ugandan experience.
First, regulation. As demand for morphine expands, ade-
quate supply at national level must be assured by forward
planning. The two functions, opioid availability and pre-
vention of narcotic abuse, should be separate as too many
legal obstacles for busy health professionals are a disin-
centive to use. No country has recorded diversion of ther-
apeutic oral morphine to illegal use and many experts
believe that stiff controls could be relaxed, at least at the
prescriber-patient level [13]. There is no reason, if district
orders match district estimates, that morphine cannot be
obtained in the same way as other drugs.
Second, on-going support. It is important that the pallia-
tive care programme is owned by district health authori-
ties. Although initial district training is costly in terms of
nurse time, transportation and per diems, new money is
now becoming available through the Global Fund and the
President's Emergency Plan For AIDS Relief which
includes funding for palliative care. Monitoring the qual-
ity of the service is important as palliative care nurses
work in isolated environments. The Palliative Care Associ-
ation of Uganda, under the umbrella of the new pan-Afri-
can Palliative Care Association (APCA), aims to help
develop and promote standards.
Third, nurse training. In Uganda it takes 9 months to
become a specialist palliative care nurse (and be allowed
to prescribe). Since 1993, 600 health professionals have
been trained. Some question the length of training in view
of the huge unmet need. But, if shortened, nurses' ability
to diagnose pain accurately and prescribe effectively
might be jeopardised. The Director of HAU suggests that
the Ugandan training programme could be adapted to
suit different health infrastructures and different types of
nurses and proposes that a group of nurses and one doctor
could be trained per region, who could then train others.
Fourth, the use of community volunteers. Community
based volunteers are essential but lack of funding, regula-
tion, training and support are concerns [14,15]. In
Zambia, it was shown that transport costs alone
accounted for 33% of home-carer costs [16]. HAU
believes that without a proper palliative care component
home care can be equated to home neglect [17]. The
answer might be for clinical staff to lead and supervise a
team of carers including traditional healers.
Table 1: Audit data: observation of nurse consultations in patients' homes (n = 21) and file reviews
Yes Frequency (Percent) No Frequency (Percent) Missing
Pain measurement questions
Was there a measure of quality of life (sleep and mobility)? 17 (81%) 4 (19%) 0
Was the pain scale (VAS) used to monitor pain? 5 (23.8%) 16 (76.2%) 0
Was duration of the pain noted? 18 (85.7%) 3 (14%) 0
Consultation quality indicators
Were patient's views on morphine sought? 6 (28.6%) 15 (71.4%) 1
Were instructions clearly given? 19 (90.5%) 2 (9.5%) 1
Were side effects discussed? 14 (66.7%) 7 (33.3%)
Was a laxative prescribed? 14 (66.7%) 5 (23.8%) 2 (9.5%)
Was the patient fully examined? 13 (61.9%) 7 (33.3%) 1
Was a follow up date arranged? 21 (100%) 0 0
Were details of the prescription written in notes? 20 (95.2%) 0 1 (4.8%)
Financial costs of illness are only one aspect. At home or in hospital, relatives have to care for the sick and this may result in the principal bread 
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Fifth, the danger of health care costs displacing other
essentials such as food. Forty-two percent of monthly
Ugandan household expenditure is spent on food [18],
and illness diverts money from this. A WHO sponsored
survey in Botswana, Ethiopia, Tanzania, Zimbabwe and
Uganda [19] identified practical needs of the dying and
found loss of income was a huge problem for two thirds
of the patients. Multi-sectoral links between a palliative
care service and organisations supplying food and poverty
reduction are essential to alleviate health-related family
poverty.
Conclusion
The magnitude of unnecessary suffering in countries like
Uganda is so huge that pain relief should be as important
a public health priority as anti-retroviral therapy, and the
two closely linked. As money becomes available from the
Global Fund, and as 15% of PEPFAR funding has been tar-
geted for palliative care, this will help support other
national palliative care programmes. But careful plan-
ning, education and monitoring are necessary. The Ugan-
dan experience may be seen as a result of concerted
lobbying and policy wok through HAU, which is likely to
be necessary in other countries that wish to replicate their
success. A recent review of palliative care in Sub-Saharan
Africa found a chronic lack of African-relevant evidence
on outcomes in palliative care [20,21] despite a wealth of
practitioner experience. It is hoped that lessons learnt
from Uganda will add to the knowledge and encourage
other countries to adopt similar programmes to relieve
the epidemic of silent suffering.
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